• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    PTC Therapeutics, Inc. (PTCT)

    -NasdaqGS
    70.48 Down 0.88(1.23%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:71.36
    Open:70.89
    Bid:67.01 x 300
    Ask:73.00 x 200
    1y Target Est:99.90
    Beta:-2.138
    Next Earnings Date: 4-May-15PTCT Earnings announcement
    Day's Range:70.42 - 73.01
    52wk Range:14.51 - 78.72
    Volume:337,899
    Avg Vol (3m):654,524
    Market Cap:2.37B
    P/E (ttm):N/A
    EPS (ttm):-2.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PTCTDown 1.23%2.37B
    SRPTDown 1.76%554.97M
    VRTXDown 1.93%32.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):92.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-5.22
    Quarterly EPS Est (Mar-15) :-1.20
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback